outlines how the company secretly pursued a plan dubbed project tango to be an end to end pain provider. the company allegedly examined selling overdose anecdotes as complimentary products to the same doctors it sold the opioids to citing internal documents the lawsuit shows the company deferred to drug dependent people as quote an attractive market. the attorney general s office accusing the sackler family of deceiving doctors and patients about the risks and profiting off the sale of the drug while blaming the terrible consequences to the people who became addicted. the complaint cites an e-mail from richard sackler who wrote we have to hammer on the abusers in every way possible. they are the culprits and the problem. they are reckless criminals. the lawsuit includes a chart
crisis. the owners of purdue pulled in nearly $4 billion both selling opioids and the drugs used to treat opioid addiction. the lawsuit goes on to claim that purdue pushed pain killers on doctors and patients while denying that the drugs were causing overdoses and deaths. let s speak to cnn national correspondent to break it all down. it is a story not just on profiting but hiding the effects of the drugs at the same time. the central claim is that the company was trying to both sell the drugs and the remedy for the addiction to it all at the same time. the nearly 300 page complaint one of the richest families outlines how the company secretly pursued a plan dubbed project tango to become an end to end pain provider. the company allegedly examined selling overdose ant dotes like
according to a new lawsuit purdue pharma has profited off the country s addiction problem for decades, all while downplaying the public health crisis. miguel marquez joins us this morning with more. the attorney general of massachusetts saying it is an audacious plan by the company to sell the drug and the cure. nearly 300-page complaint against purdue pharma and the family outlines how they pursued a plan dubbed project tango to be an end to end pain provider. the company allegedly examined selling overdo dosdose antidote narcan to the same doctors it sold opioids to including oxycontin. citing internal documents the lawsuit shows the company referred to drug dependent people as, attractive markets that could earn the company billions. the massachusetts attorney